Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP2R5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MCM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHORDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
APTX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRLS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM120A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACYBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS26A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on